Idibell

Researcher Laura Valle, awarded with a L’Oréal-UNESCO fellowship

Leave a Comment / Cancer, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

Laura Valle, researcher of the Bellvitge Biomedical Research Institute (IDIBELL) at the Catalan Institute of Oncology (ICO), has received a fellowship of the program L’Oréal-UNESCO “For Women in Science”. The award, presented on September 6th in Seville under the “XXII International Congress of Biochemistry and Molecular Biology”, was delivered to five young Spanish female scientists […]

Researcher Laura Valle, awarded with a L’Oréal-UNESCO fellowship Read More »

IDIBELL organizes an international conference on diseases of the immune system

Leave a Comment / Cancer Epigenetics / By

The Bellvitge Biomedical Research Institute (IDIBELL) organizes an international cancer conference on diseases affecting the immune system, specifically those related to lymphocytes (immune system cells responsible for acquired immunity) that can be altered in leukemias, lymphomas, autoimmune and immunodeficiency diseases. The conference will take place on the 13th-14th September at the Ateneu Barcelonès, in the

IDIBELL organizes an international conference on diseases of the immune system Read More »

Anorexia nervosa and obesity share common characteristics

Leave a Comment / Neuroscience Area, Neuroscience Program, Psychoneurobiology of Eating and Addictive Behaviours / By

Groups with extreme weight conditions can share biological risk factors and neurocognitive characteristics Alterations in neuronal circuits related to motivation and reward Common characteristics between anorexia nervosa and obesity Reference of the paper

Anorexia nervosa and obesity share common characteristics Read More »

IDIBELL and Mind the Byte signed collaboration agreement

Leave a Comment / Innovation / By

IDIBELL and the company Mind the Byte have signed a cooperation agreement to carry out joint research activities. The framework agreement of cooperation includes the exchange of research personnel, the project development and the use of scientific facilities. Innovative technology to facilitate research Mind the Byte is a Catalan R&D company located on the Bellvitge

IDIBELL and Mind the Byte signed collaboration agreement Read More »

Researchers have developed a computer application to identify representative proteins in metastatic breast cancer

Leave a Comment / Cancer / By

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have created a software application called MinerProt, which allows the classification of proteins by their function. The system, created in collaboration with researchers from the Polytechnic University of Catalonia (UPC) and Pompeu Fabra University (UPF), is useful to prioritize the importance of some proteins. The study was

Researchers have developed a computer application to identify representative proteins in metastatic breast cancer Read More »

Michael Aschner: “We want to develop strategies for neuroprotection from Manganese”

Leave a Comment / Innovation, Outreach and education / By

Last July 13th, Michael Aschner PhD, from the Department of Pediatrics, Vanderbilt University Medical Center in Nashville (USA), gave the IDIBELL seminar “From worms to humans: mechanisms of manganese induced neurotoxicity and lessons for dopaminergic cell loss“ in the framework of the FENS Forum, hold in Barcelona. The main objective of the study leaded by

Michael Aschner: “We want to develop strategies for neuroprotection from Manganese” Read More »

José Ramon Naranjo: “Inhibiting DREAM could improve the Huntington disease”

Leave a Comment / Innovation, Outreach and education / By

“The inhibition of DREAM could improve Huntington disease”, said Dr. José Ramón Naranjo from the Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB-CSIC), in his seminar “DREAM: interactions, targets and functions” at the Hospital Duran i Reynals last July 6th. DREAM is a transcriptional repressor in the nucleus and regulates the traffic

José Ramon Naranjo: “Inhibiting DREAM could improve the Huntington disease” Read More »

Laboratory technician students from Portugal visited IDIBELL

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Neurometabolic diseases , Neuroscience Area, Neuroscience Program, Outreach and education, Tumor and stromal chemoresistance  / By

Five students for laboratory technician from Portugal visited today IDIBELL facilities. On arrival, the laboratory technician from the Neurometabolic diseases research group Juan Jose Martínez has talk about the work of laboratory technicians in a research centre as the IDIBELL. Then, the students have visited the animal facilities, where technician Rosa Bonavia explained the functioning

Laboratory technician students from Portugal visited IDIBELL Read More »

More shadows than lights in the smoke-free laws

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

On July 5, one hundred participants and twenty speakers from different countries met at this International Symposium, jointly organized by the ICO and the WHO. This first Symposium was devoted to analyzing the experience of Spain and other countries that have implemented partial smoke-free laws or that have suffered regressive processes by the establishment of

More shadows than lights in the smoke-free laws Read More »

Jason Mundin: “It was a simple idea, but the most complicated was to make it work”

Leave a Comment / Innovation, Outreach and education / By

Jason Mundin, MBA, Director of Collaborations at Population Genetics, gave a Knowledge and Technology Transfer seminar, presenting his company, last 25th July in IDIBELL. Population Genetics, created in 2005 by Dr Sydney Brenner, Nobel Laureate in Medicine, has developed novel sequencing approaches to identify variants in candidate genomic regions in populations ranging in size from

Jason Mundin: “It was a simple idea, but the most complicated was to make it work” Read More »

Scroll to Top